[go: up one dir, main page]

DK3126373T3 - Fremgangsmåde til fremstilling af amg 416 - Google Patents

Fremgangsmåde til fremstilling af amg 416 Download PDF

Info

Publication number
DK3126373T3
DK3126373T3 DK15773570.5T DK15773570T DK3126373T3 DK 3126373 T3 DK3126373 T3 DK 3126373T3 DK 15773570 T DK15773570 T DK 15773570T DK 3126373 T3 DK3126373 T3 DK 3126373T3
Authority
DK
Denmark
Prior art keywords
amg
procedure
manufacturing
manufacturing amg
Prior art date
Application number
DK15773570.5T
Other languages
English (en)
Inventor
Jeroen Bezemer
Ying Chen
Richard Crockett
Sheng Cui
Liang Huang
Sian Jones
Asher Lower
Krishnakumar Ranganathan
Kevin Crossley
Original Assignee
Amgen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=54241346&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK3126373(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Amgen Inc filed Critical Amgen Inc
Application granted granted Critical
Publication of DK3126373T3 publication Critical patent/DK3126373T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/02—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length in solution
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
    • C07K1/1072—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides by covalent attachment of residues or functional groups
    • C07K1/1075—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides by covalent attachment of residues or functional groups by covalent attachment of amino acids or peptide residues
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/18—Drugs for disorders of the endocrine system of the parathyroid hormones
    • A61P5/20—Drugs for disorders of the endocrine system of the parathyroid hormones for decreasing, blocking or antagonising the activity of PTH

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Analytical Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Glass Compositions (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK15773570.5T 2014-04-03 2015-04-03 Fremgangsmåde til fremstilling af amg 416 DK3126373T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201461974899P 2014-04-03 2014-04-03
PCT/US2015/024347 WO2015154031A1 (en) 2014-04-03 2015-04-03 Method for preparing amg 416

Publications (1)

Publication Number Publication Date
DK3126373T3 true DK3126373T3 (da) 2020-05-04

Family

ID=54241346

Family Applications (1)

Application Number Title Priority Date Filing Date
DK15773570.5T DK3126373T3 (da) 2014-04-03 2015-04-03 Fremgangsmåde til fremstilling af amg 416

Country Status (27)

Country Link
US (3) US10407464B2 (da)
EP (3) EP3126373B1 (da)
JP (1) JP6710158B2 (da)
KR (1) KR102397271B1 (da)
CN (3) CN106795201A (da)
AU (1) AU2015240527B2 (da)
CA (1) CA2944194C (da)
CL (1) CL2016002513A1 (da)
CY (1) CY1123100T1 (da)
DK (1) DK3126373T3 (da)
EA (1) EA032597B1 (da)
ES (2) ES2943671T3 (da)
HR (1) HRP20200527T1 (da)
HU (1) HUE048489T2 (da)
IL (1) IL248059B2 (da)
LT (1) LT3126373T (da)
MA (2) MA52906A (da)
ME (1) ME03781B (da)
MX (1) MX374205B (da)
PL (1) PL3126373T3 (da)
PT (1) PT3126373T (da)
RS (1) RS60187B1 (da)
SG (1) SG11201608176VA (da)
SI (1) SI3126373T1 (da)
SM (1) SMT202000207T1 (da)
WO (1) WO2015154031A1 (da)
ZA (1) ZA201606844B (da)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014210489A1 (en) * 2013-06-28 2014-12-31 Amgen Inc. Stable liquid formulation of amg 416 (velcalcetide)
WO2015154031A1 (en) 2014-04-03 2015-10-08 Amgen Inc. Method for preparing amg 416
CN106928320B (zh) * 2015-12-31 2021-01-15 深圳翰宇药业股份有限公司 一种合成Etelcalcetide的方法
CN106928321B (zh) * 2015-12-31 2019-07-26 深圳翰宇药业股份有限公司 一种合成Etelcalcetide的方法
CN109641946A (zh) * 2016-03-23 2019-04-16 巴切姆股份公司 胰高血糖素样肽的制备方法
US10858390B2 (en) 2016-09-02 2020-12-08 Cem Corporation Use of excess carbodiimide for peptide synthesis at elevated temperatures
CN108101959B (zh) * 2016-11-24 2021-07-09 四川科伦药物研究院有限公司 一种制备高纯度多肽或其类似物的方法
CN106928171B (zh) * 2017-05-03 2019-08-13 成都郑源生化科技有限公司 Fmoc-Arg（Pbf）-OH的合成方法
TW201915009A (zh) * 2017-10-03 2019-04-16 中化合成生技股份有限公司 合成依特卡肽（Ｅｔｅｌｃａｌｃｅｔｉｄｅ）或其鹽類之方法
CN110498835B (zh) * 2018-05-17 2021-06-08 深圳翰宇药业股份有限公司 一种合成etelcalcetide的方法
CN109280078B (zh) * 2018-10-30 2019-06-25 成都诺和晟泰生物科技有限公司 一种制备维拉卡肽的方法
CN112062811B (zh) * 2019-06-10 2022-03-25 深圳翰宇药业股份有限公司 一种维拉卡肽的合成方法
US20220298206A1 (en) * 2019-08-26 2022-09-22 Auro Peptides Ltd An improved process for the preparation of Etelcalcetide Hydrochloride
EP3875466A1 (en) * 2020-03-05 2021-09-08 Fresenius Kabi iPSUM S.r.l. Process for the synthesis of etelcalcetide
CN115698032A (zh) 2020-06-03 2023-02-03 中外制药株式会社 困难序列的高效的肽缩合法
CN111925415A (zh) * 2020-08-10 2020-11-13 海南中和药业股份有限公司 一种维拉卡肽杂质的制备方法
TWI792442B (zh) 2021-07-23 2023-02-11 建誼生技股份有限公司 依特卡肽鹽酸鹽之製造方法
CN114524860B (zh) * 2021-12-29 2025-01-24 深圳翰宇药业股份有限公司 一种Etelcalcetide的合成方法及其应用

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3941763A (en) 1975-03-28 1976-03-02 American Home Products Corporation PGlu-D-Met-Trp-Ser-Tyr-D-Ala-Leu-Arg-Pro-Gly-NH2 and intermediates
EP0339695A3 (en) 1988-04-29 1990-05-30 Stichting Voor De Technische Wetenschappen A process for preparing an antigenic or immunogenic conjugate as well as the use of such conjugates
SE9603465D0 (sv) 1996-09-23 1996-09-23 Astra Ab New compounds
NO311807B1 (no) * 1999-03-04 2002-01-28 Bionor Immuno As HIV-peptider, antigener, vaksinepreparater, immunoassay- testsett og en metode for påvisning av antistoffer fremkalt av HIV
CN101835794A (zh) 2007-10-27 2010-09-15 霍夫曼-拉罗奇有限公司 使用固相和溶液相组合技术的促胰岛素肽合成法
CN101250172B (zh) 2008-03-07 2012-05-02 上海瀚鸿化工科技有限公司 精氨酸双保护制备工艺
EP2427474A1 (en) 2009-05-06 2012-03-14 Mallinckrodt LLC Solid support for fmoc-solid phase synthesis of peptide acids
LT3192520T (lt) * 2009-07-29 2019-06-25 Kai Pharmaceuticals, Inc. Terapiniai agentai, skirti paratiroidinio hormono lygių sumažinimui
WO2011133346A1 (en) * 2010-04-21 2011-10-27 Pharmacofore, Inc. Peripheral opioid agonists and peripheral opioid antagonists
AU2011301147A1 (en) * 2010-09-08 2013-04-18 Howard Florey Institute Of Experimental Physiology And Medicine Modified relaxin polypeptides
WO2013042129A1 (en) 2011-09-23 2013-03-28 Natco Pharma Limited Improved process for preparation of bivalirudin
WO2014210489A1 (en) 2013-06-28 2014-12-31 Amgen Inc. Stable liquid formulation of amg 416 (velcalcetide)
WO2015154031A1 (en) 2014-04-03 2015-10-08 Amgen Inc. Method for preparing amg 416
CN105504012A (zh) * 2014-09-30 2016-04-20 深圳翰宇药业股份有限公司 一种多肽的制备方法
CN107434820A (zh) * 2017-08-07 2017-12-05 南京工业大学 一种维拉卡肽的合成方法

Also Published As

Publication number Publication date
US10407464B2 (en) 2019-09-10
EA201692001A1 (ru) 2017-02-28
LT3126373T (lt) 2020-05-11
CN119874825A (zh) 2025-04-25
EP3126373A4 (en) 2018-06-20
SMT202000207T1 (it) 2020-05-08
ZA201606844B (en) 2018-07-25
CA2944194C (en) 2022-04-19
EP3126373A1 (en) 2017-02-08
JP2017511332A (ja) 2017-04-20
SG11201608176VA (en) 2016-10-28
ES2786225T3 (es) 2020-10-09
MX374205B (es) 2025-03-05
CN106795201A (zh) 2017-05-31
ME03781B (me) 2021-04-20
PT3126373T (pt) 2020-04-24
EP4219526A2 (en) 2023-08-02
US11377474B2 (en) 2022-07-05
US20170190739A1 (en) 2017-07-06
HUE048489T2 (hu) 2020-07-28
WO2015154031A1 (en) 2015-10-08
IL248059B2 (en) 2023-10-01
BR112016022868A2 (pt) 2018-07-03
AU2015240527B2 (en) 2019-09-26
CY1123100T1 (el) 2021-10-29
CA2944194A1 (en) 2015-10-08
IL248059B1 (en) 2023-06-01
PL3126373T3 (pl) 2020-07-27
MA52906A (fr) 2021-04-21
KR20170026326A (ko) 2017-03-08
EP4219526A3 (en) 2023-08-30
CN119899242A (zh) 2025-04-29
US20230099078A1 (en) 2023-03-30
HRP20200527T1 (hr) 2020-06-26
JP6710158B2 (ja) 2020-06-17
MX2016012965A (es) 2017-07-06
CL2016002513A1 (es) 2018-03-23
SI3126373T1 (sl) 2020-06-30
ES2943671T3 (es) 2023-06-15
EP3126373B1 (en) 2020-03-04
MA39628B1 (fr) 2020-05-29
EP3708576B1 (en) 2023-02-22
KR102397271B1 (ko) 2022-05-16
US20190352336A1 (en) 2019-11-21
IL248059A0 (en) 2016-11-30
EA032597B1 (ru) 2019-06-28
AU2015240527A1 (en) 2016-10-20
EP3708576A1 (en) 2020-09-16
RS60187B1 (sr) 2020-06-30

Similar Documents

Publication Publication Date Title
FIC20230006I1 (fi) Vutrisiraani
DK3126373T3 (da) Fremgangsmåde til fremstilling af amg 416
DK3192902T3 (da) Fremgangsmåde til fremstilling af graphenholdige viscosefibre
DK3405050T3 (da) Børnesikret snusbeholder
DK3096741T3 (da) Fremgangsmåde til fremstillingen af hybridosomer
DK3072835T3 (da) Fremgangsmåde til fremføring
DK3325443T3 (da) Fremgangsmåde til fremstilling af pridopidin
DK3294700T3 (da) Fremgangsmåde til fremstilling af limonen-4-ol
DK3174858T3 (da) Fremgangsmåde til fremstilling af pyrazoler
DK3507408T3 (da) Fremgangsmåde til fremstilling af nonwoven
DK3436823T3 (da) Antigen-array
DK3125898T3 (da) Farmakofor til trail-induktion
DK3335532T3 (da) Tandharve
DK3402792T3 (da) Quinolin-2-on-derivater
DK3445708T3 (da) Stigbøjle
DK3529233T3 (da) Fremgangsmåde til fremstilling af 3-alkylsulfanyl-2-chlor-n-(1-alkyl-1h-tetrazol-5-yl)-4-trifluoromethyl-benzamider
DK3280408T3 (da) Fremgangsmåde til fremstilling af dicycloplatin
DK3438103T3 (da) Griseofulvinforbindelse
DK3452590T3 (da) Plademagnet
EP3498837A4 (en) Genome editing method
EP3490399A4 (en) INTERCONNECTS
DE112017000734A5 (de) Glycolsensor
DK3149422T3 (da) Anordning til fremstilling af cementklinker
DE112017006386A5 (de) Schraubarbeitszylinder
DK3323708T3 (da) Bovfender